Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-019109
Filing Date
2024-11-14
Accepted
2024-11-14 16:00:05
Documents
1
Group Members
KEVIN TANGTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 lenz1015247sc13ga1.htm SC 13G/A 84654
  Complete submission text file 0001214659-24-019109.txt   86541
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

EIN.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Subject) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92660 | Film No.: 241461370
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)